-
Making Their Mark
With targeted therapy options available for a growing number of cancer types, biomarker testing is making a difference for more people with solid cancers.
by Kendall K. Morgan
-
Cancer Care for Older Adults
Geriatric assessments can help physicians and older patients choose effective treatments with fewer side effects.
by Eric Fitzsimmons
-
Q&A
Solving a Medical MysteryJournalist Lawrence Ingrassia traces the scientific history of a genetic disorder that predisposes families like his to cancer.
by Thomas Celona
-
Forward Look
Cognition and Prostate CancerAndrogen deprivation therapy, a common prostate cancer treatment, may increase cognitive difficulties.
by Joseph Jalkiewicz
-
Rethinking the Role of Radiation
Chest radiation may not be necessary for people with intermediate-risk breast cancer.
by Thomas Celona
-
De-escalating Treatment for DCIS
Research finds certain people with low-risk DCIS may be able to forgo surgery or radiation.
by Thomas Celona
-
Study Highlights Challenges in Pancreatic Cancer Staging
Most pancreatic ductal adenocarcinoma cases initially considered to be stage I are changed to a higher stage after surgery.
by Taneia Surles
-
Understanding How High and Low Testosterone Levels Can Treat Prostate Cancer
Using high-dose testosterone after prostate cancer stops responding to androgen deprivation therapy can stop tumor growth.
by Sandra Gordon
-
Aggressive Approach to Very Advanced Cancer Does Not Extend Survival
Study shows no benefit from treatment for cancers at very advanced stages of progression. Researchers urge end-of-life planning for these patients.
by Kyle Bagenstose
-
The Affordable Care Act’s Impact on Access to Cancer Care
A study at the AACR Cancer Health Disparities Conference found more people got quality cancer care after the ACA went into effect.
by Cancer Research Catalyst
Cancer Talk
Injection Immunotherapies Get FDA Approval
Giving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
Designing Clinical Trials for the PatientChallenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons
Treating Smoldering Multiple MyelomaA monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore